Unlock instant, AI-driven research and patent intelligence for your innovation.

Hyperpolarized esters as metabolic markers in MR

A technology of hyperpolarization and metabolites, applied in the field of 13C-MR research, which can solve problems such as undetectable

Active Publication Date: 2015-10-14
BRACCO IMAGINIG SPA
View PDF12 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

related to dialkyl 13 C succinate (i.e. an alkyl 13 The primary metabolite of the esterase reaction of C succinate cannot be detected by the method exemplified in this application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hyperpolarized esters as metabolic markers in MR
  • Hyperpolarized esters as metabolic markers in MR
  • Hyperpolarized esters as metabolic markers in MR

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0117] General Carboxylesterase Activity in Example 1 Cancer Cells

[0118] General carboxylesterase activity was determined spectrophotometrically using the carboxylesterase substrate 1-naphthyl acetate (NA) as described above (Rudakova, 2011). Briefly, sonicated cells were incubated with 1 mM substrate in 150 mM phosphate buffer (pH 7.5), 1-naphthol production was monitored at 322 nm and quantified according to its extinction coefficient (2200 M-1 cm-1). The reaction was allowed to proceed at 30 degrees for 10 min. The substrate concentration and temperature are chosen so as to obtain assay conditions under which the assay exhibits linear performance.

[0119] The following is a reaction scheme for a general esterase detection assay:

[0120]

[0121] Cells from different sources (rat hepatoma, Morris; human hepatoma, HepG2; human prostate cancer, PC-3; human breast cancer, MCF-7) were harvested and redissolved in phosphate buffered saline to 10 million cells / ml conce...

Embodiment 2

[0126] Example 2. Using hyperpolarized [1,3- 13 C 2 Carboxylesterase activity determined by ]-ethyl acetoacetate

[0127] 2.a. Hyperpolarized [1,3- 13 C 2 ]-Production of ethyl acetoacetate

[0128] A) The carboxylic acid form of the Finland group (0.85 mg, 0.82 μmol) was dissolved in [1,3- 13 C 2 ]-Ethyl acetoacetate (48 μl, 50.1 mg, 0.378 mmol). To this solution was added the gadolinium complex [[α1,α4,α7-tris[(phenylmethoxy)methyl]-1,4,7,10-tetraazacyclododecane-1,4,7 , 10-tetraacetic acid (4-)] gadolinite (gadolinite) (1-)] hydrogen in DMSO solution (1.1mg100μmol / g solution). The concentrations of radical and gadolinium were 17 mM and 2.3 mM, respectively.

[0129] B) Hyperpolarization of a 30 μmol solution of A). The samples were dissolved in 5 ml of phosphate buffer (40 mM, pH 7.3). The pH after dissolution was 7.3.

[0130] 2.b. Using hyperpolarized [1,3- 13 C 2 ]-Ethyl acetoacetate in rat hepatoma cells Carboxylesterase activity measure...

Embodiment 3

[0136] Example 3. Hyperpolarized [1,3- 13 C 2 ]-Ethyl acetoacetate with hyperpolarized [1- 13 Comparison between C]-pyruvate metabolism

[0137] Copolarized [1,3- 13 C 2 ]-Ethyl acetoacetate and [1- 13 C]-pyruvate experiments were performed which resulted in concentrations of approximately 3.5 mM of each substrate in the experiments. [1,3- 13 C 2 ]- DNP preparation of ethyl acetoacetate was carried out as described in WO2006 / 011809 [1- 13DNP preparation of C]-pyruvate. The two substrates are copolarized without mixing the substrates. The substrate mixture was injected into 10 million cells in suspension after dissolving in 5 ml of phosphate buffer (40 mM pH 7.3) and adding 2.5 μl of NaOH to neutralize pyruvate (thereby converting it to the pyruvate anionic form). Experiments were performed as described in Example 2.b. Data are presented as the area under the metabolite curve divided by the substrate signal in the first spectrum and multiplied by 100 to give units, D...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method of Magnetic Resonance (MR) detection, in particular 13C-MR detection, by using a diagnostic medium comprising a hyperpolarized ester, in particular ethyl acetoacetate. The method comprises the detection of the MR signal of a hyperpolarized 13C carboxylic ester and of its respective hyperpolarized metabolite.

Description

field of invention [0001] The present invention relates to the field of magnetic resonance (MR), and in particular to the use of 13 C esters of diagnostic media 13 C-MR research methods. Background of the invention [0002] Magnetic resonance imaging (MRI) has become a particularly attractive technique for clinicians because images of a patient's body or parts of it can be obtained non-invasively without exposing the patient and medical staff to potentially harmful radiation such as X-rays - in the ray. Due to its high quality images and good spatial and temporal resolution, MRI is an advantageous imaging technique for imaging soft tissues and organs. MRI can be done with or without MR contrast agents. However, enhanced MRI imaging is often able to detect very small tissue changes, making it a powerful tool for detecting early stage tissue changes such as small tumors or metastases. [0003] MRI using hyperpolarized molecules is an emerging technique. WO 9935508 disclo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K49/10
CPCA61K49/10A61K49/06A61K51/04
Inventor P·R·杰森M·H·莱尔凯M·卡尔松C·卡贝拉S·考洛姆伯赛拉L·米拉戈利L·文图里F·泰多蒂
Owner BRACCO IMAGINIG SPA